NEWARK, Del, June 26, 2024 (GLOBE NEWSWIRE) -- The IV therapy and vein access devices market is expected to reach USD 28.7 billion by 2024. From 2024 to 2034, revenue is expected to increase by 5.1% ...
It’s a common practice — maintaining peripheral intravenous catheters (PIVCs) in stable hospital patients even after the need for IV therapy has been resolved. And the thinking goes, why not? After ...
Is intraosseous vascular access associated with poorer patient outcomes than intravenous access after out-of-hospital cardiac arrest? In a secondary analysis, published in Annals of Emergency Medicine ...
Patients with testicular cancer had fewer venous access-related complications and overall thrombotic events when first-line chemotherapy was delivered via peripheral intravenous access compared with ...
The global IV therapy and vein access devices market is on a trajectory of significant growth, projected to expand from USD 28.7 billion in 2024 to an estimated USD 47.3 billion by 2034. With a ...
Many hospital patients get medicine or nutrition delivered straight into their bloodstream through a tiny device called a PICC. In just a decade, it's become the go-to device for intravenous care. But ...
According to a report published by Future Market Insights, the IV treatment and vein access devices industry is anticipated to produce US$ 44.4 billion over the course of the projected year, with a ...
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non–Small-Cell Lung Cancer Treated in the US Community Setting We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results